Institutional investors purchased a net $7.7 million shares of NBIX during the quarter ended June 2015 and now own 97.74% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 1.4 Million shares of Neurocrine Biosciences In...